Efficacy of Low Level LASER Therapy in Treating Temporomandibular Muscle Disorders

Ain Shams University56 enrolled

Overview

This study aimed to evaluate the sustainability of the efficacy of using low level laser therapy and CAD/CAM Michigan splint in improving the range of mandibular movements, muscle activity and reducing the pain.

56 female patients were randomly divided into two groups, Group A: Patients received applications of low-level laser therapy using semiconductor InGaAsp diode LASER type 940 nm with continuous mode of operation, with time of application 180 sec per session for 12 sessions. Group B: Patients received hard occlusal splints (Michigan splints) of 2 mm thickness constructed on their upper teeth, the hard occlusal splint was 3D digitally printed. ARCUS digma facebow was used to evaluate the range of mandibular movements affected from TMJ problems. The opening measurements of the patient were taken using a millimeter ruler. Electromyogram (EMG) was used to evaluate muscle activity. Visual analogue scale (VAS) was used to evaluate the pain intensity. All was done before the beginning of the treatment at three and six months follow up period.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Temporomandibular Joint Dysfunction Syndrome

Interventions

Low Level LASER therapyRADIATION

using semiconductor InGaAsp diode LASER type 940 nm with continuous mode of operation, with time of application 180 sec per session for 12 sessions.

Hard occlusal splintDEVICE

2 mm thickness occlusal splint constructed over the maxillary arch using CAD/CAM technology.

Eligibility

Sex: FEMALEMin age: 35 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: tenderness in the TMJ or muscles of mastication (e.g., temporalis and masseter) that might get worse in the morning or with eating, headache, periauricular pain, teeth wear that appears in the form of multiple smooth shinny facets, teeth mobility, and malocclusion Exclusion Criteria: * pregnant females, breast feeders, patients having pacemakers, heart disease, tumors, general connective tissue disease e.g., Rheumatoid arthritis, psychiatric disorders, skeletal morphology as class II or III, TMJ clicking sounds, local skin infection over the masseter or temporalis, symptoms that may be referred to other disorders of orofacial region (tooth ache, trigeminal neuralgia, migraine), or patients using medications such as Muscle relaxant, Steroids, Dopamine precursors like L dopa and Aminoglycoside * Vulnerable groups (prisoners, mental disorders, patients not capable of decision making).

Locations (1)

faculty of dentistry, Ain Shams University

Cairo, Egypt

Outcomes

Primary Outcomes

Electromyographic muscle activity

The change in muscle activity was assessed using EMG in terms of Microvolt

Time frame: Measured 3 times through 6 months from the beginning of the treatment. (0,3,6 months)

Range of mandibular movement

The increase in the range of movement measured using ARCUS digma in terms of angular inclination.

Time frame: Measured 3 times through 6 months from the beginning of the treatment. (0,3,6 months)

Secondary Outcomes

Pain intensity

The degree of pain is assessed using a 10 cm scale (VAS)

Time frame: Measured 3 times through 6 months from the beginning of the treatment. (0,3,6 months)

Mouth opening

degree of mouth opening in cm using ruler

Time frame: Measured 3 times through 6 months from the beginning of the treatment. (0,3,6 months)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.